Carson Wealth (CWM LLC)’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Buy
5,600
+248
+5% +$4.21K ﹤0.01% 3217
2025
Q4
$72K Buy
5,352
+820
+18% +$10.1K ﹤0.01% 3327
2025
Q3
$53K Buy
4,532
+73
+2% +$681 ﹤0.01% 3486
2025
Q2
$29K Buy
4,459
+1,796
+67% +$11.8K ﹤0.01% 3675
2025
Q1
$16K Buy
2,663
+1,195
+81% +$8.56K ﹤0.01% 3834
2024
Q4
$10K Sell
1,468
-37
-2% -$255 ﹤0.01% 3880
2024
Q3
$9K Buy
1,505
+235
+19% +$1.63K ﹤0.01% 3841
2024
Q2
$9K Sell
1,270
-268
-17% -$2.34K ﹤0.01% 3612
2024
Q1
$14K Buy
1,538
+270
+21% +$1.54K ﹤0.01% 3139
2023
Q4
$5K Sell
1,268
-595
-32% -$1.79K ﹤0.01% 3524
2023
Q3
$6K Hold
1,863
﹤0.01% 3383
2023
Q2
$7K Hold
1,863
﹤0.01% 3288
2023
Q1
$6K Sell
1,863
-3
-0.2% -$10 ﹤0.01% 3219
2022
Q4
$4K Sell
1,866
-1,968
-51% -$5.46K ﹤0.01% 3308
2022
Q3
$14K Buy
3,834
+1,915
+100% +$18.4K ﹤0.01% 2475
2022
Q2
$18K Buy
+1,919
New +$24.3K ﹤0.01% 2193
2022
Q1
Sell
-1,309
Closed -$27K 3736
2021
Q4
$27K Buy
+1,309
New +$41.8K ﹤0.01% 1833
2021
Q2
$72K Buy
+1,393
New +$73.1K ﹤0.01% 1254

Other funds holding DFTX

Carson Wealth (CWM LLC)'s DFTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Definium Therapeutics (DFTX) stake by 4.6% in Q1 2026, buying an estimated $4.21K and bringing the position to 5,600 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

Carson Wealth (CWM LLC) first reported a position in DFTX in Q2 2021 and has held it in 18 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 5,600 shares of Definium Therapeutics worth $106K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 248 Definium Therapeutics shares in Q1 2026, an estimated $4.21K.
  • Definium Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3217 holding.
  • Carson Wealth (CWM LLC) first reported a position in Definium Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.